Interleukin-34 Serum leveland disease activity In Children with Systemic Lupus Erythematosus

Interleukin-34 Serum leveland disease activity In Children with Systemic Lupus Erythematosus

Background: Pediatric-onset systemic lupus erythematosus (pSLE) is an autoimmune disease with multiorgan involvement and accounts for 15% to 20% of all systemic lupus erythematosus(SLE) cases. Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease characterized by variable immune...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:NeuroQuantology 2022-01, Vol.20 (6), p.7502
Hauptverfasser: Hossam Mostafa Kamal, Mohammed Mohammed Abd El salam Ahmad Mokhtar Ahmad Hany Suliman Selem Awadallah
Format: Artikel
Sprache:eng
Schlagworte:
Amino acids
Autoimmune diseases
Chronic conditions
Creatinine
Cytokines
Disease
Females
Homology
Interleukins
Lupus
Males
Medicine
Mortality
Nephrology
Pediatrics
Proteins
Puberty
Rheumatoid arthritis
Rheumatology
Signs and symptoms
Urine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Pediatric-onset systemic lupus erythematosus (pSLE) is an autoimmune disease with multiorgan involvement and accounts for 15% to 20% of all systemic lupus erythematosus(SLE) cases. Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease characterized by variable immune dysregulation, disabling symptoms, and progressive organ damage. Interleukin (IL)−34 is a newly discovered cytokine that has no significant amino acid sequence homology to other cytokines.
ISSN:1303-5150
DOI:10.14704/nq.2022.20.6.NQ22751